TNToru Nishi

Toru Nishi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Toru Nishi has a total of 10 co-authors. Here are the top co-authors by number of shared publications:

  • Gunter A. Hofmann

    Department of Neurosurgery, Kumamoto University School of Medicine, 1-1-1 Honjo, Kumamoto, 860-8556, Japan; ‡Shionogi Institute for Medical Science, 2-5-1 Mishima, Settsu, Osaka, 566-0022, Japan; and §Genetronics, Inc., 11199 Sorrento Valley Road, San Diego, CA 92121

    1 shared publication
  • Hideo Takeshima

    Department of Neurosurgery, Kumamoto University School of Medicine, 1-1-1 Honjo, Kumamoto, 860-8556, Japan; ‡Shionogi Institute for Medical Science, 2-5-1 Mishima, Settsu, Osaka, 566-0022, Japan; and §Genetronics, Inc., 11199 Sorrento Valley Road, San Diego, CA 92121

    1 shared publication
  • Jun-Ichi Kuratsu

    Department of Neurosurgery, Kumamoto University School of Medicine, 1-1-1 Honjo, Kumamoto, 860-8556, Japan; ‡Shionogi Institute for Medical Science, 2-5-1 Mishima, Settsu, Osaka, 566-0022, Japan; and §Genetronics, Inc., 11199 Sorrento Valley Road, San Diego, CA 92121

    1 shared publication
  • Kimio Yoshizato

    Department of Neurosurgery, Kumamoto University School of Medicine, 1-1-1 Honjo, Kumamoto, 860-8556, Japan; ‡Shionogi Institute for Medical Science, 2-5-1 Mishima, Settsu, Osaka, 566-0022, Japan; and §Genetronics, Inc., 11199 Sorrento Valley Road, San Diego, CA 92121

    1 shared publication
  • Masato Kochi

    Department of Neurosurgery, Kumamoto University School of Medicine, 1-1-1 Honjo, Kumamoto, 860-8556, Japan; ‡Shionogi Institute for Medical Science, 2-5-1 Mishima, Settsu, Osaka, 566-0022, Japan; and §Genetronics, Inc., 11199 Sorrento Valley Road, San Diego, CA 92121

    1 shared publication
  • Sukhendu B. Dev

    Department of Neurosurgery, Kumamoto University School of Medicine, 1-1-1 Honjo, Kumamoto, 860-8556, Japan; ‡Shionogi Institute for Medical Science, 2-5-1 Mishima, Settsu, Osaka, 566-0022, Japan; and §Genetronics, Inc., 11199 Sorrento Valley Road, San Diego, CA 92121

    1 shared publication

Latest Publications

  • Highly efficient electro-gene therapy of solid tumor by using an expression plasmid for the herpes simplex virus thymidine kinase gene

    by Tomoaki Goto, Toru Nishi, Takahiko Tamura, Sukhendu B. Dev, Hideo Takeshima, Masato Kochi, Kimio Yoshizato, Jun-Ichi Kuratsu, Tsuneaki Sakata, Gunter A. Hofmann, et al.

    We report successful electro-gene therapy (EGT) by using plasmid DNA for tumor-bearing mice. Subcutaneously inoculated CT26 tumor was subjected to EGT, which consists of intratumoral injection of a naked plasmid encoding a marker gene or a therapeutic gene, followed by in vivo electroporation (EP). When this treatment modality is carried out with the plasmid DNA for the green fluorescent protein gene, followed by in vivo EP with the optimized pulse parameters, numerous intensely bright green fluorescent signals appeared within the tumor. EGT, by using the “A” fragment of the diphtheria toxin gene significantly inhibited the growth of tumors, by about 30%, on the flank of mice. With the herpes simplex virus thymidine kinase gene, followed by systemic injection of ganciclovir, EGT was far more effective in retarding tumor growth, varying between 50% and 90%, compared with the other controls. Based on these results, it appears that EGT can be used successfully for treating murine solid tumors.